Human ventricular modelling and simulation of drug action on electrophysiology and contraction
Drug safety and efficacy assessment remains as one of the biggest challenges in both preclinical and clinical drug development. Cardiac adverse outcomes may emerge even though they did not occur in early stages of drug development. Among them, the prediction of drug action on cardiac contraction and...
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Conference item |
| Kieli: | English |
| Julkaistu: |
IEEE
2021
|